Anti-cancer DC Cell Vaccination to Treat Solid Tumors
Clinical trial NCT06477614 · RECRUITING
Trial details
- NCT number
- NCT06477614
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-05
- Primary completion
- 2030-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.